Clinical Trial Update: Bariatric Surgery and Pharmacokinetics of Lisdexamphetamine

View source ↗

Summary

A completed clinical trial evaluating how bariatric surgery affects the pharmacokinetics of lisdexamfetamine in individuals with morbid obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Obesity, Morbid | Status: COMPLETED